yanxiang ni

Mrs. yanxiang ni


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in iScience
Verified
Journal Article
Open access
RLRaozhou Lin
Raozhou Lin
ZDZhigang Duan
Zhigang Duan
HSHaitao Sun
Haitao Sun
MFMan-Lung Fung
Man-Lung Fung
Hansen ChenHansen Chen
Hansen Chen
JHJIANDONG HUANG
JIANDONG HUANG
N-methyl-D-aspartate (NMDA) receptor (NMDAR) is highly compartmentalized in neurons, and its dysfunction has been implicated in various neuropsychiatric and neurodegenerative disorders. Recent failure to exploit NMDAR antagonization as a potential therapeutic target has driven the need to identify molecular mechanisms that regulate NMDAR compartmentalization. Here, we report that the reduction of Kif5b, the heavy chain of kinesin-1, protected neurons against NMDA-induced excitotoxicity and ischemia-provoked neurodegeneration. Direct binding of kinesin-1 to the GluN2B cytoplasmic tails regulated the levels of NMDAR at extrasynaptic sites and the subsequent influx of calcium mediated by extrasynaptic NMDAR by regulating the insertion of NMDARs into neuronal surface. Transient increase of Kif5b restored the surface levels of NMDAR and the decreased neuronal susceptibility to NMDA-induced excitotoxicity. The expression of Kif5b was repressed in cerebral ischemia preconditioning. Our findings reveal that kinesin-1 regulates extrasynaptic NMDAR targeting and signaling, and the reduction of kinesin-1 could be exploited to defer neurodegeneration.

16 November 2021 in Nanophotonics
Verified
Journal Article
Open access
PDF file
JNJielei Ni
Jielei Ni
BCBo Cao
Bo Cao
GNGang Nui
Gang Nui
DCDanni Chen
Danni Chen
GLGuotao Liang
Guotao Liang
YNyanxiang ni
yanxiang ni
Single‐molecule localization microscopy (SMLM) plays an irreplaceable role in biological studies, in which nanometer‐sized biomolecules are hardly to be resolved due to diffraction limit unless being stochastically activated and accurately located by SMLM. For biological samples preimmobilized for SMLM, most biomolecules are cross‐linked and constrained at their immobilizing sites but still expected to undergo confined stochastic motion in regard to their nanometer sizes. However, few lines of direct evidence have been reported about the detectability and influence of confined biomolecule stochastic motion on localization precision in SMLM. Here, we access the potential stochastic motion for each immobilized single biomolecule by calculating the displacements between any two of its localizations at different frames during sequential imaging of Alexa Fluor‐647‐conjugated oligonucleotides. For most molecules, localization displacements are remarkably larger at random frame intervals than at shortest intervals even after sample drift correction, increase with interval times and then saturate, showing that biomolecule stochastic motion is detected and confined around the immobilizing sizes in SMLM. Moreover, localization precision is inversely proportional to confined biomolecule stochastic motion, whereas it can be deteriorated or improved by enlarging the biomolecules or adding a post‐crosslinking step, respectively. Consistently, post‐crosslinking of cell samples sparsely stained for tubulin proteins results in a better localization precision. Overall, this study reveals that confined stochastic motion of immobilized biomolecules worsens localization precision in SMLM, and improved localization precision can be achieved via restricting such a motion.

6 June 2024 in Nanophotonics
Verified
Journal Article
Open access
PDF file
ZJZhe Jia
Zhe Jia
LZLingxiao Zhou
Lingxiao Zhou
HLHaoyu Li
Haoyu Li
JNJielei Ni
Jielei Ni
DCDanni Chen
Danni Chen
YNyanxiang ni
yanxiang ni
Precisely pinpointing the positions of emitters within the diffraction limit is crucial for quantitative analysis or molecular mechanism investigation in biomedical research but has remained challenging unless exploiting single molecule localization microscopy (SMLM). Via integrating experimental spot dataset with deep learning, we develop a new approach, Digital‐SMLM, to accurately predict emitter numbers and positions for sub‐diffraction‐limit spots with an accuracy of up to 98 % and a root mean square error as low as 14 nm. Digital‐SMLM can accurately resolve two emitters at a close distance, e.g. 30 nm. Digital‐SMLM outperforms Deep‐STORM in predicting emitter numbers and positions for sub‐diffraction‐limited spots and recovering the ground truth distribution of molecules of interest. We have validated the generalization capability of Digital‐SMLM using independent experimental data. Furthermore, Digital‐SMLM complements SMLM by providing more accurate event number and precise emitter positions, enabling SMLM to closely approximate the natural state of high‐density cellular structures.

8 April 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
BCBo Cao
Bo Cao
JNJielei Ni
Jielei Ni
GNGang Niu
Gang Niu
DCDanni Chen
Danni Chen
GLGang Liu
Gang Liu
YNyanxiang ni
yanxiang ni
Single molecule localization microscopy (SMLM) is irreplaceable among super-resolution microscopies in revealing biological ultra-structures, given its unmatched high resolution. However, its sub-optimal quantitative capability, which is critical for characterizing true biomolecular organization of ultra-structures in cells, has hindered its widest application in biomedical research. Here, in SMLM imaging of cellular structures such as lipid rafts and microtubules with saturation labelling, we identified ultra-bright localizations, each of which is contributed by simultaneous emission of multiple molecules within a diffraction-limit region and has been regarded before as a regular localization from single molecule. Consistently, ultra-bright localizations are also observed in simulated SMLM imaging of endoplasmic reticulum or microtubules from public resource. Furthermore, after calibrating each ultrabright localization into multiple single-molecule localizations using the photon-number-based models, the density of total localizations shows linear correlation with the true molecule density, presenting SMLM with new reconstruction method as a quantitative analysis approach. Therefore, identification and dissection of ultra-bright localizations in SMLM enable the close and quantitative estimate of the true biomolecular organization.

13 February 2025 in Nanophotonics
Verified
Journal Article
Open access
PDF file
HWHanzhe Wu
Hanzhe Wu
DCDanni Chen
Danni Chen
YJYihong Ji
Yihong Ji
GXGan Xiang
Gan Xiang
YNyanxiang ni
yanxiang ni
JQJunle Qu
Junle Qu
Among the approaches in three‐dimensional (3D) single molecule localization microscopy, there are several point spread function (PSF) engineering approaches, in which depth information of molecules is encoded in 2D images. Usually, the molecules are excited sparsely in each raw image. The consequence is that the temporal resolution has to be sacrificed. In order to improve temporal resolution and ensure localization accuracy, we propose a method, SH‐CS, based on light needle excitation, detection system with single helix‐point spread function (SH‐PSF), and compressed sensing (CS). Although the SH‐CS method still has a limitation about the molecule density, it is suited for relatively dense molecules. For each light needle scanning position, an SH image of excited molecules is processed with CS algorithm to decode their axial information. Simulations demonstrated, for random distributed 1–15 molecules in depth range of 4 μm, the axial localization accuracy is 12.1–73.5 nm. The feasibility of this method is validated with a designed 3D sample composed of fluorescent beads.

1 January 2023 in BIOCELL
Verified
Journal Article
Open access
PDF file
YWYafei Wang
Yafei Wang
JNJielei NI
Jielei NI
YLYuhan Liu
Yuhan Liu
DLDingying Liao
Dingying Liao
QZQianwen Zhou
Qianwen Zhou
YNyanxiang ni
yanxiang ni
Down syndrome (DS) is a genetic condition characterized by intellectual disability, delayed brain development, and early onset Alzheimer’s disease. The use of primary neural cells and tissues is important for understanding this disease, but there are ethical and practical issues, including availability from patients and experimental manipulability. Moreover, there are significant genetic and physiological differences between animal models and humans, which limits the translation of the findings in animal studies to humans. Advancements in induced pluripotent stem cells (iPSC) technology have revolutionized DS research by providing a valuable tool for studying the cellular and molecular pathologies associated with DS. Induced pluripotent stem cells derived from cells obtained from DS patients contain the patient’s entire genome including trisomy 21. Trisomic iPSCs as well as their derived cells or organoids can be useful for disease modeling, investigating the molecular mechanisms, and developing potential strategies for treating or alleviating DS. In this review, we focus on the use of iPSCs and their derivatives obtained from DS individuals and healthy humans for DS research. We summarize the findings from the past decade of DS studies using iPSCs and their derivatives. We also discuss studies using iPSC technology to investigate DS-associated genes (e.g., APP, OLIG1, OLIG2, RUNX1, and DYRK1A) and abnormal phenotypes (e.g., dysregulated mitochondria and leukemia risk). Lastly, we review the different strategies for mitigating the limitations of iPSCs and their derivatives, for alleviating the phenotypes, and for developing therapies.